Biotechnology In Japan
Download Biotechnology In Japan full books in PDF, epub, and Kindle. Read online free Biotechnology In Japan ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Malcolm V. Brock |
Publisher | : Taylor & Francis |
Total Pages | : 114 |
Release | : 2024-11-01 |
Genre | : Social Science |
ISBN | : 1040229468 |
In the early 1980s, biotechnology caused worldwide excitement as a high technology with almost unlimited potential in science, medicine, and industry. It not only allowed the manufacture of traditional products more quickly and inexpensively, but also offered the possibility of synthesizing valuable materials anew. All this made it very attractive to Japanese policymakers, who ‘targeted’ it as a high priority area for economic growth. Originally published in 1989, Biotechnology in Japan is the first published in English to analyse the Japanese effort to promote the new biotechnology industries. The author examines the strategies used for developing biotechnology in Japan and looks at the active role of government in a field in which the Japanese rapidly became the world leaders. Focusing on the making and implementation of biotechnology policy, he considers the relationship between the public and the private sector, and makes use of different political constructs to analyse Japan’s complex and unique balance between competitive market forces and collective interest.
Author | : Robert Yuan |
Publisher | : Springer |
Total Pages | : 330 |
Release | : 1990-06-18 |
Genre | : Science |
ISBN | : 1349117625 |
Author | : Mark D. Dibner |
Publisher | : McGraw-Hill Companies |
Total Pages | : 344 |
Release | : 1989 |
Genre | : Business & Economics |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 604 |
Release | : 1984 |
Genre | : Biological products |
ISBN | : |
Author | : Hans-Georg Dederer |
Publisher | : Springer |
Total Pages | : 379 |
Release | : 2019-08-16 |
Genre | : Law |
ISBN | : 3030171191 |
This book provides in-depth insights into the regulatory frameworks of five countries and the EU concerning the regulation of genome edited plants. The country reports form the basis for a comparative analysis of the various national regulations governing genetically modified organisms (GMOs) in general and genome edited plants in particular, as well as the underlying regulatory approaches.The reports, which focus on the regulatory status quo of genome edited plants in Argentina, Australia, Canada, the EU, Japan and the USA, were written by distinguished experts following a uniform structure. On this basis, the legal frameworks are compared in order to foster a rational assessment of which approaches could be drawn upon to adjust, or to completely realign, the current EU regime for GMOs. In addition, a separate chapter identifies potential best practices for the regulation of plants derived from genome editing.
Author | : B.M. Knoppers |
Publisher | : Springer Science & Business Media |
Total Pages | : 520 |
Release | : 2012-12-06 |
Genre | : Business & Economics |
ISBN | : 1461553113 |
Biotechnology is a rapidly developing sector of the economy for coun tries throughout the world. This rapid development has led to heated debate over its risks and benefits. Advocates of biotechnology point to the potential benefits offered by products that promise to elimi nate disease, provide for more efficient diagnostic techniques, treatments and drugs, yield increased food production, and so forth. Others fear that the rapid developments of this technology have occurred without appropriate consideration having been given to the ethical ramifications, the potential health risks and long-term envi ronmental impacts, implications for income distribution, and potential for abuse. Consumers and producers share concern for the future of biotechnology: the realities and even the perceptions, informed or otherwise. This book is the outcome of a research project on Biotechnology and the Consumer sponsored by the Office of Consumer Affairs of Industry Canada. The project was designed to foster informed public policy on biotechnology and in particular, to contribute to and inform the Canadian government's development of a Canadian Biotechnology Strategy. The Office funded a group of authors to prepare a series of analytical papers on a range of consumer and informational issues related to biotechnology. This project also involved an interim workshop in which the authors presented their papers, and culmi nated in a symposium on Biotechnology and the Consumer Interest, held on September 24-25, 1997, in Ottawa, Canada.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 225 |
Release | : 1991-02-01 |
Genre | : Medical |
ISBN | : 030904491X |
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Author | : Bryan Bergeron |
Publisher | : John Wiley & Sons |
Total Pages | : 384 |
Release | : 2004-04-12 |
Genre | : Business & Economics |
ISBN | : 0471647578 |
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Author | : Cornelia Storz |
Publisher | : Routledge |
Total Pages | : 178 |
Release | : 2006-01-16 |
Genre | : Business & Economics |
ISBN | : 1134207514 |
This new book discusses the extent to which the Japanese economy encourages entrepreneurship and innovation. Although Japan has a strong reputation as an innovator, some people argue that this reputation is misplaced. Contrary to earlier expectations, the USA rather than Japan emerged as the leader in the biotech industries in the 1990s, and also many small firms in Japan supply only a few – or just one – other company, thereby limiting their view of the marketplace and the commercial opportunities within it. Despite the increase of international patents, international scientific citations and a positive technology trade balance, the Japanese innovation system is weak in giving birth to radical innovations. The book explores fully these issues, making comparisons with other countries where appropriate. It concludes that the Japanese innovation system has both advantages and disadvantages and contributes to a better understanding of how policy changes take place.
Author | : I. Endo |
Publisher | : Elsevier |
Total Pages | : 239 |
Release | : 2000-03-17 |
Genre | : Science |
ISBN | : 0080528155 |
The bioseparation engineering of today includes downstream process engineering such as waste water, material and gas treatment. Taking this tendency into account, bioseparation engineers gathered in Japan as a special research group under the main theme of "Recovery and Recycle of Resources to Protect the Global Environment".The scope of this book is based on the conference, and deals not only with recent advances in bioseparation engineering in a narrow sence, but also the environmental engineering which includes waste water treatment and bioremediation. The contributors of this book cover many disciplines such as chemical engineering, analytical chemistry, biochemistry, and microbiology.Bioseparation Engineering will stimulate young engineers and scientists who will develop bioseparation engineering further in the 21st century, and contribute to a world-wide attention to the global environment